Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?".
about
Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?".
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@en
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@nl
type
label
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@en
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@nl
prefLabel
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@en
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@nl
P2093
P2860
P356
P1476
Reply to "Are there reasons to ...... ommunity-acquired pneumonia?".
@en
P2093
David N Fisman
Kevin A Brown
Nagham Khanafer
Nick Daneman
P2860
P356
10.1128/AAC.00864-13
P407
P577
2013-08-01T00:00:00Z